Who Paid My Doc
Aequalis Ascend Flex
Device Trauma & Extremities
PDI 03700386944475
General payments
$1,465,835
Research payments
$615,368
Through program year 2025, $1,465,835 in general payments and $615,368 in research payments were reported against Aequalis Ascend Flex (Trauma & Extremities).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $217,569 | 728 |
| 2025 | Research | $32,193 | 27 |
| 2024 | General | $234,450 | 849 |
| 2024 | Research | $139,123 | 48 |
| 2023 | General | $396,184 | 690 |
| 2023 | Research | $231,739 | 26 |
| 2022 | General | $410,301 | 641 |
| 2022 | Research | $212,313 | 15 |
| 2021 | General | $207,331 | 480 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 25 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 42 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,388 general · 116 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.